SARS-CoV-2 extensively N-glycosylates its spike proteins, which are essential for host cell invasion, target of vaccines, and immunotherapy. These N-glycans are predicted to help mediate spike binding to the host receptor. We investigated the essentiality of the host N-glycosylation pathway and virus N-glycans for infection.